McDermott, M.S.J.; Sharko, A.C.; Munie, J.; Kassler, S.; Melendez, T.; Lim, C.-u.; Broude, E.V.
CDK7 Inhibition Is Effective in all the Subtypes of Breast Cancer: Determinants of Response and Synergy with EGFR Inhibition. Cells 2020, 9, 638.
https://doi.org/10.3390/cells9030638
AMA Style
McDermott MSJ, Sharko AC, Munie J, Kassler S, Melendez T, Lim C-u, Broude EV.
CDK7 Inhibition Is Effective in all the Subtypes of Breast Cancer: Determinants of Response and Synergy with EGFR Inhibition. Cells. 2020; 9(3):638.
https://doi.org/10.3390/cells9030638
Chicago/Turabian Style
McDermott, Martina S. J., Amanda C. Sharko, Jessica Munie, Susannah Kassler, Theresa Melendez, Chang-uk Lim, and Eugenia V. Broude.
2020. "CDK7 Inhibition Is Effective in all the Subtypes of Breast Cancer: Determinants of Response and Synergy with EGFR Inhibition" Cells 9, no. 3: 638.
https://doi.org/10.3390/cells9030638
APA Style
McDermott, M. S. J., Sharko, A. C., Munie, J., Kassler, S., Melendez, T., Lim, C.-u., & Broude, E. V.
(2020). CDK7 Inhibition Is Effective in all the Subtypes of Breast Cancer: Determinants of Response and Synergy with EGFR Inhibition. Cells, 9(3), 638.
https://doi.org/10.3390/cells9030638